title: [The clinico-bacteriological and pharmacokinetic evaluation of vancomycin in clinical practice].
abstract: Clinical application of vancomycin in 24 patients produced a response in 83.3% of the patients. The drug was active against pneumococcal pneumonia, bronchitis, staphylococcal endocarditis and mastitis. Positive pharmacokinetic parameters of the drug allows introduction of the antibiotic 1-2 times daily.
authors.forename: V A
authors.initials: VA
authors.lastname: Orlov
authors.forename: V I
authors.initials: VI
authors.lastname: Sokolova
authors.forename: V A
authors.initials: VA
authors.lastname: Shenderovich
authors.forename: E V
authors.initials: EV
authors.lastname: Troshina
mesh_terms: D000208:Acute Disease; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy; D002908:Chronic Disease; D006801:Humans; D008826:Microbial Sensitivity Tests; D013997:Time Factors; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology*
chemical_list: D014640:Vancomycin
vernacular_title: Kliniko-bakteriologicheskaia i farmakokineticheskaia otsenka vankomitsina v klinicheskoĭ praktike.